<DOC>
	<DOCNO>NCT02388152</DOCNO>
	<brief_summary>The purpose study determine multiple immunization Lu AF20513 tolerable safe patient mild Alzheimer 's disease .</brief_summary>
	<brief_title>A Study Evaluate Safety Tolerability New Drug Named Lu AF20513 Patients With Mild Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Main The patient diagnosis probable Alzheimer 's Disease ( AD ) consistent National Institute Neurological Communicative Disorders Stroke Alzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) criteria The patient pattern antibodies cerebrospinal fluid ( CSF ) consistent amyloid plaque load The patient man woman , ≥60 ≤85 year age The patient MRI ( perform within 3 month screen ) result consistent diagnosis probable AD The patient mild severity dementia The patient knowledgeable reliable caregiver available able : accompany patient clinical visit , monitor IRE immunization , participate patient phone visit study AD Patients must complete Part A eligible continued immunisation Part B Main The patient evidence mixed etiology dementia ( i.e . absence neurodegenerative , neuroinflammatory cerebrovascular disease , another neurological , mental systemic disease condition likely contribute cognitive decline ) The patient clinical radiological finding fulfil standard National Institute Neurological Disorders Stroke Association Internationale pour la Recherché et l'Enseignement en Neurosciences ( NINDSAIREN ) criteria vascular dementia The patient Diagnostic Statistical Manual Mental Disorders , 4th edition , Text Revision ( DSMVTR ) Axis I disorder AD ; include amnestic disorder , delirium , schizophrenia schizoaffective disorder , bipolar disorder , current major depressive episode , psychosis , panic , posttraumatic stress disorder and/or cognitive disorder otherwise specify , ( note : patient may include treat stable dose antidepressant least 2 month fulfil DSMVTR criterion depression Screening ) The patient 's eligibility MRI scan ( 1.5T ) show finding correspond 4 brain micro haemorrhages The patient extensive white matter lesion show screen MRI scan ( 1.5T ) Other protocoldefined inclusion exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>